Summary
Hepatitis C virus RNA (HCV-RNA) was serially assayed in the serum and peripheral blood mononuclear cells (PBMC) of 10 patients with chronic hepatitis C who underwent interferon (IFN) therapy, and whether detection of HCV-RNA from PBMC serves as an index of the response of chronic hepatitis C to IFN therapy was evaluated. HCV-RNA was assayed by reversed transcription and polymerase chain reaction using the 5′-noncoding region as a primer. IFN therapy was effective in 3 patients and ineffective in the other 7 patients. HCV-RNA disappeared from the serum during and immediately after the IFN therapy in all 3 patients in whom the therapy was effective and in 3 of 7 patients in whom the therapy was ineffective. HCV-RNA desappeared from PBMC in all 3 patients in whom the therapy was effective, but PBMC HCV-RNA remained positive in 6 of the 7 patients in whom the therapy was ineffective, and the serum HCV-RNA became positive again in 5 of these 6 patients after 6 months. The disappearance of HCV-RNA from PBMC was associated with long-term stabilization of the serum alanine aminotransferase value, so HCV-RNA assay in PBMC is considered to be useful as a prognostic marker of chronic hepatitis C after IFN therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hoofnagle JH, Mullen KD, Jones DB, et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 1986;315:1575–1578.
Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis with recombinant interferon alfa. N Engl J Med 1989;321:1501–1506.
Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon alfa therapy for chronic hepatitis C. N Engl J Med 1989;321:1506–1510.
Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359–362.
Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362–364.
Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with nonA, non-B hepatitis. Proc Natl Acad Sci USA 1990;87:9524–9528.
Takamizawa A, Mori C, Fuke I, et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 1991;65:1105–1113.
Okamoto H, Okada S, Sugiyama Y, et al. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J Gen Virol 1991;72:2697–2704.
Choo Q-L, Richman KH, Han JH, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991 ;88: 2451–2455.
Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1987;239:487–491.
Okamoto H, Okada S, Sugiyama Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5’noncoding region. Japan J Exp Med 1990;60:215–222.
Weiner AJ, Kuo G, Bradley DW, et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 1990;335:1–3.
Kaneko S, Unoura M, Kobayashi K, et al. Detection of serum hepatitis C virus RNA. Lancet 1990;335:976.
Hagiwara H, Hayashi N, Mita E, et al. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α. Hepatology 1992;15:37–41.
Chayama K, Saitoh S, Arase Y, et al. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. 1991;13:1040–1043.
Shindo M, Di Bisceglie AM, Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis C treated with α-interferon. Hepatology 1992;15:1013–1016.
Kanai K, Iwata K, Nakao K, et al. Suppression of hepatitis C virus RNA by interferon-α. 1990;336:245.
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–159.
Arrigo S, Weitsman S, Rosenblatt JD, et al. Analysis of rev gene function on hyman immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method. J Virol 1989;63:4875–4881.
Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237–238.
Aach RD, Stevens CE, Hollinger FB, et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first-and second-generation assays. N Engl J Med 1991;325:1325–1329.
Nakatsuji Y, Matsumoto A, Tanaka E, et al. Detection of chronic hepatitis C virus infection by four diagnostic systems: First-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 1992;16:300–305.
Craxi A, Fiorentino G, Marco VD, et al. Second generation tests in diagnosis of chronic hepatitis C. Lancet 1991;337:1354.
Kondo T. Evaluation of the antiviral effect of interferon therapy for chronic hepatitis C. Acta Hepat Jap 1992;33:591–599. (in Japanese with English abstracts)
Hellings JA, Van der Veen-du Prie J, Snelting-Van Densen R, et al. Preliminary results of transmission experiments of non-A, non-B hepatitis by mononuclear leucocytes from a chronic patient. J Virol Methods. 1985;10:321–326.
Takamatsu K, Koyanagi Y, Okita K, et al. Hepatitis C virus RNA in saliva. Lancet 1990;336:1515.
Kato N, Yokosuka O, Omata M, et al. The relationship between the amount of hepatitis C virus quantified by competitive RT-PCR (CRT-PCR) and the effect of interferon treatment. Acta Hepat Jap 1991;32:750–751. (in Japanese)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Okuda, M. HCV-RNA assay in peripheral blood mononuclear cells in relation to IFN therapy. Gastroenterol Jpn 28, 535–540 (1993). https://doi.org/10.1007/BF02776952
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02776952